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ABSTRACT 
 
Aim: To study the aetiology, precipitating insults of patients presenting with acute on chronic liver failure and 
predictors of mortality of acute chronic liver failure. Methods: The prospective study was carried out in 100 patients 
admitted with acute on chronic liver failure for a period of 1 year in the Department of Medicine of Government 
medical college and Hospital, Jammu. Results: ACLF has a predominant male preponderance i.e 92 %. The mean 
age of patients presenting with ACLF was 45.39 ± 1.1 yrs. Among causes of chronic liver disease alcohol was 
commonest (79 %) followed by Alcohol + Hepatitis C (4.0 %) ,Alcohol + hepatitis B (1 %), Hepatitis B (1 %), 
Hepatitis C (3 %), NASH related (4 %) and Auto immune (5 %).Etiologyof acute precipitants included alcohol 
(43%) followed by Alcohol with Hepatitis B/C (9 %), alcohol with Hepatitis E (4%), alcohol with hepatitis E + 
Dengue (2%), Hepatitis E (8%), Hepatitis B (8 %) and Hepatitis C (6%) ,Hepatitis E + Leptospirosis (2%), 
leptospirosis (1%) and gastrointestinal bleed + others etiology (14%) were other causes of acute etiology in patients 
of acute on chronic liver failure. The mean SOFA, MELD and MDF scores were found to be better predictors of 
mortality. Conclusion: ACLF carries a high mortality rate. Alcohol was found to be the most common cause of 
chronic etiology of Chronic liver disease as well as acute insult. Scoring systems such as SOFA, MELD and MDF 
scores were considered to better predictors of mortality. 
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Introduction 
 
 
Acute on chronic liver failure (ACLF) is an intense 
deterioration of a chronic liver disease distinct from 
acute liver failure and decompensated chronic liver 
ailment [1]. This term was first employed in 1995 to 
depict  a condition in which two insults to liver are 
operatingat the same time, one of them being ongoing 
and chronic and the other acute [2].There have been 
different reports and definitions of what precisely 
comprises of ACL.  
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Asian Pacific Association for the Study of the Liver 
(APASL) explained it as “acute hepatic insult 
establishing as jaundice (defined as serum bilirubin 
level ≥5 mg/dL) and coagulopathy (defined as 
international normalized ratio ≥1.5), complicated 
within 4 weeks by ascites and/or encephalin a patient 
with previously diagnosed or undiagnosed chronic liver 
disease (Sarin S et al 2014)[3]. In terms of precipitating 
events, primary hepatitic insult counting reactivation of 
hepatitis B virus (HBV) as well as secondary viral 
insults with hepatitis E virus (HEV) and hepatitis A 
virus (HAV) frame a major cause in the east, and 
APASL definition per se prohibits bacterial infection as 
a precipitating event [4]. More current components like 
dengue fever and malaria infection are too being 
considered as acute etiological factors in Acute on 
chronic liver failure. A recent EASL-CLIF consortium 
prospectively analyzeda expansive cohort of patients to 
particularly characterize various organ failures, to 
survey different variables anticipating mortality and to 
create a prognosticating model [5-7]. The consortium 
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moreover modified the existing Sequential Organ 
Failure Assessment (SOFA) score utilized 
byintensivists and formulated a new CLIF-SOFA score 
to address various issues particularly related with liver 
failure and cirrhosis.In such circumstances, research 
and advancement of various proprietary artificial and 
bio artificial liver devices to supplement liver functions 
in settings of ACLF may make a modern skyline [8]. 
Studies on ACLF are limited, heterogeneous, and 
mostly retrospective. It is pertinent to study the 
etiological profile of ACLF patients, factors predicting 
their mortality, for understanding the natural course of 
ACLF and developing newer treatment modalities to 
lessen the mortality. 
 
Materials and Methods 
The present observational, cross-sectional analytical 
study was conducted on patients defined by Asian 
Pacific Association for the Study of the Liver (APASL 
GUIDELINES) 2014 [3]admitted with acute on 
chronic liver failure for a period of 1 year in the Post 
graduate Department of Internal Medicine, 
Government Medical College and Associate Hospitals, 
Jammu, a tertiary care hospital w.e.f November 1st 
2016 to October 31st, 2017.Informed consent was 
taken from the first degree relatives (FDRs) of the 
patient for enrollment in the trial. The study was 
presented for approval, to the Institutional Ethical 
Committee, prior to the enrollment of patients into the 
study.  
 
Method of collection of data 
Acute hepatic insult (1 or more) were defined from the 
following etiologies such as Infectious etiology 
(Hepatotropic and non-hepatotropic viruses, 
reactivation of Hepatitis B (overt or occult) or Hepatitis 
C and other infectious agents afflicting the liver) and 
non infectious etiology (Alcohol: active drinking 
within the last four weeks, use of hepatotoxic drugs, 
herbs, flare of autoimmune hepatitis or Wilson’s 
disease, surgical intervention, variceal bleeding and 
Unknown hepatotoxic etiology. 
Chronic liver disease was based on clinical, radiologic 
and endoscopic criteria. The presence of any of the 
following was taken as evidence of underlying chronic 
liver disease: ascites with high serum-ascites albumin 
gradient, presence of esophagealvarices, hepatic 
venous pressure gradient (HVPG) >10 mm Hg, stage 
>2 fibrosis on histological analysis, or portal vein >13 
mm on ultrasonography[9] 
 
Inclusion criteria 
Consecutive patients with ACLF as defined by APASL 
were included. Every consecutive patient with 
previously diagnosed or undiagnosed chronic liver 
disease, Jaundice [serum bilirubin level >5mg/dL] and 
coagulopathy (international normalized ratio >1.5 or 
prothrombin activity < 40%) with onset of ascites 
and/or encephalopathy occurring within 4 weeks of the 
acute insult,sudden onset of acute liver disease on 
presentation with evidence of chronic liver disease 
confirmed after evaluation and age group older than 16 
years. 
 
Exclusion criteria 
Age younger than 16 years, sudden onset of acute liver 
disease on presentation with no evidence of chronic 
liver disease, patients of decompensated chronic liver 
disease in whom the presence of acute hepatic insult 
cannot be defined, patients with sepsis and patients 
with Hepato renal syndrome (HRS) 
 
Assessment of severity and organ dysfunction 
Prognostic Scores including Maddrey’s discriminant 
function (MDF) (Maddrey WC et al., 1978)[10], Model 
for end stage liver disease (MELD) (Malinchoc M et 
al., 2000[11]) and Sequential organ failure assessment 
score (SOFA) (Vincent JL et al., 1998)[12] were 
calculated for all patients as per defined by above 
guidelines.  
 
Statistical analysis 
All results are expressed as mean±standard deviation 
(SD), median (range), or frequency (in percent). 
Quantitative variables, expressed as means ±SD, were 
compared with the use of the Student's t test. 
Qualitative variables, expressed as percentages, were 
compared with the use of a chi-square test. A p value 
of <0.05 was considered statistically significant. 
Analysis was performed using SPSS software version 
23 for Windows and Microsoft Excel for Windows. 
 
Result and discussion 
Acute on chronic liver failure (ACLF) is a critical 
condition and approximately two-thirds of patients may 
die in the absence of liver transplantation. Most 
patients already have multi-organ failure at 
presentation which has a spiraling downhill effect 
leading to high mortality in these patients. The present 
study was conducted at Government Medical College 
and Associated Hospitals, Jammu and a total of 100 
patients were included in the study. 
The age of the patients in our study ranged from 22 
years to 68 years. Most of the patients belonged to age 
group of 40-49 and 51-60 years of age respectively 
(table 1). In a study from GB Pant hospital Delhi the 
median age of the patients was 36 years (range 15 to 
80) years with a predominance of males (74% vs 24%) 
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[13]. Our results were also in agreement with Moreau 
et al who reported that the  mean age of patients 
presenting with acute on chronic liver failure was 56 
years [14]. Majority of the patients were males (n= 93) 
compared to (n= 7) females (table 2). The male 
prepordance is due to the fact that major cause of 
chronic liver disease in our region is alcohol intake and 
use of alcohol is much more common in males than 
females (Table 2). Male patients consisted of 74%, 
86%, 86%, in different studies [3,4,15]. The sex 
distribution of ACLF patients is similar to that of in 
cirrhotic patients presenting to our hospital. 
The study group patients were divided into 3 subgroups 
on basis of presentation viz subgroup A (Not a known 
CLD presenting with acute decompensation), sub 
group B (Known compensated CLD presenting with 
acute decompensation) and sub group C (Known 
decompensated CLD presenting with rapid 
deterioration of liver function). Most of the patients 
belonged to sub group A. Thus undiagnosed cirrhosis 
was already present in most of the patients with ACLF. 
(Table 3) 
The etiology of chronic liver disease as well as acute 
insult was studied. In our study the most common 
cause of etiology of chronic liver disease was found to 
be to be alcohol related (79 %), Alcohol + Hepatitis C 
(4.0 %), Alcohol + hepatitis B (1 %), Hepatitis B (1 
%), Hepatitis C (3 %), NASH related (4 %) and auto 
immune (5 %) were the other common causes of 
chronic liver disease (Table 4 ). In a study from 
Osmania Medical College, Hyderabad, the most 
common cause of underlying liver disease is alcoholic 
liver disease (76 %) followed by hepatitis B (6 %). 
Among the alcoholic liver disease super added 
alcoholic hepatitis is the most common (36.8%) cause 
followed by acute hepatitis E (18.4%) [16]. In the 
western world alcoholic cirrhosis constitutes 50-70 % 
of all the underlying chronic liver diseases and 
Hepatitis B constitutes about 10-15 % of all cases [17-
19]. However in the Asian countries Hepatitis B 
constitutes 70 % and alcohol only about 15% of the 
etiology of chronic liver disease. In study published 
from Delhi the most common etiology of chronic liver 
disease was Hepatitis B followed by chronic alcohol 
abuse [13] In a recent study stated from western India 
[20]  the most common etiologies of CLD were 
hepatitis B (29.6 %) and cryptogenic (27.7%). The 
cause of chronic liver disease was due to alcohol in 
79% of our patients. Alcohol as a cause of CLD in 
relation to other causes was studied and it was not 
found to be having significant correlation with 
mortality in this subgroup of patients. In another study 
by different studies, alcohol wasfounf to be  most 
common insult followed by viral hepatitis and 
autoimmune hepatitis[21]. 
Coming on to the acute etiology in patients of acute on 
chronic liver failure, alcohol (43%) constituted the 
most common etiology of acute decompensation. 
Alcohol with Hepatitis B/C (9 %), alcohol with 
Hepatitis E (4%) and alcohol with hepatitis E + Dengue 
(2%) also constituted causes of acute etiology. 
Hepatitis E (8%), Hepatitis B (8 %) and Hepatitis C 
(6%) are other common causes of acute etiology. 
Hepatitis E + Leptospirosis (2%), leptospirosis (1%) 
and gastrointestinal bleed + others etiology (14%) were 
other causes of acute etiology in patients of acute on 
chronic liver failure (Table 5).  Our results were in 
coherent with another study in which the etiology of 
underlying cirrhosis was alcohol in majority of patients 
(59%) with alcoholic hepatitis being the most common 
acute precipitating event, occurring in 43% of patients 
[22].In another study [15]which  statedthat alcoholic 
liver disease (68%) was the most common etiology of 
cirrhosis in ACLF. Similar pattern of acute 
decompensation was found again like western world 
with alcohol being the most common causei.e 25% 
[23].Thus, there is a significant difference between 
etiologies of acute as well as chronic disease among 
northern and western India; alcohol being the major 
contributing factor in our population group. 
The prognostic factors determining the outcome of 
patients with cirrhosis and multi-organ failure are 
currently under evaluation. In our study,the mean 
SOFA score was 7.63 in patients with poor clinical 
outcome (death) and 6.57 in patients with good clinical 
outcome (alive)and had a significant correlation with 
the mortality and clinical outcome of the patients.. The 
mean MELD score was 32.31 and 27.17 in patients 
with poor and good clinical outcome respectively. The 
mean MDF score was 71.84 in patients with poor 
clinical outcome as compared to 51.28 in patients with 
good clinical outcome (Table 6).In a similar study 
conducted it was observed that sequential assessment 
of organ dysfunction (SOFA) during the first few days 
of ICU admission is a good indicator of prognosis. 
Both the mean and highest SOFA scores are 
particularly useful predictors of outcome[24].In 
aanalogousstudy 50 patients admitted to a six bed 
multidisciplinary ICU with SIRS were consecutively 
enrolled in the study and SOFA scores were calculated 
at zero hour, after 48 hrs, and after 96 hrs and patients 
were followed till discharge from hospital[25]. Hence, 
the SOFA scoring system was found to be useful in 
predicting outcomes in ICU and thus help in proper 
utilization of ICU resources  
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Table 1: Age group wise distribution of the patients 
(n=100) 
 
Age group Number Percentage 
20-29 10 10.00 
30-39 19 19.00 
40-49 31 31.00 
50-59 31 31.00 
60-69 9 9.00 
Total 100 100.00 
Mean age 45.39 
SD age 10.72 
 
Table 2: Sex distribution (n=100) 
 
Sex Number Percentage 
Male 93 93.00 
Female 7 7.00 
Total 100 100.00 
 
Table 3: Distribution of patients according to group 
(n=100) 
 
 Group Number Percentage 
Subgroup 
A 
Not a known CLD 
presenting with acute 
decompensation 
53 53.00 
Subgroup 
B 
Known compensated 
CLD presenting with 
acute decompensation 
37 37.00 
Subgroup 
C 
Known 
decompensated CLD 
presenting with rapid 
deterioration of liver 
function 
10 10.00 
Total 100 100.00 
 
Table 4: Etiology of Chronic Disease in Patients of 
acute on Chronic  Liver Failure (ACLF) (n=100) 
 
Chronic Disease Etiology Number Percentage 
Alcohol (AL) 79 79.00 
Alcohol + Hepatitis B (AL+B) 1 1.00 
Alcohol + Hepatitis C (AL+C) 4 4.00 
Hepatitis B (B) 1 1.00 
Hepatitis C (C) 3 3.00 
NASH (N) 4 4.00 
Auto immune (Al) 5 5.00 
Unknown (U) 3 3.00 
Total 100 100.00 
 
 
 
Table 5: Etiology of Acute Disease in Patients of 
Acute on Chronic Liver Failure (ACLF) (n=100) 
 
Acute disease etiology Number Percentage 
Alcohol (AL) 43 43.00 
Alcohol + Hepatits E (AL+E) 4 4.00 
Alcohol + Hepatitis B/C 
(AL+B/C) 
9 9.00 
Alcohol + Hepatits E + 
Dengue fever (AL+L+D) 
2 2.00 
Acute Hepatitis B (B) 8 8.00 
Acute Hepatitis C (C) 6 6.00 
Acute Hepatitis E (E) 8 8.00 
Hepatitis E + Leptospirosis 
(E+L) 
2 2.00 
Hepatits A + Hepatitis E 
(A+E) 
1 1.00 
Leptospirosis (L) 1 1.00 
Liver abscess (LA) 1 1.00 
GI bleed + Other etiology 
(GIB+OTH) 
14 14.00 
Unknown (U) 1 1.00 
Total 100 100.00 
 
Table 6: Relation of Scoring Systems MDF, MELD 
and SOFA to clinical Outcome in Patients of Acute on 
Chronic Liver Failure (n=100) 
 
 
 
MDF MELD SOFA 
Mean SD Mean SD Mean SD 
Alive 51.28 26.94 27.17 7.83 6.57 3.08 
Death 71.84 47.71 32.31 9.58 7.63 2.90 
Total 62.38 40.68 29.95 9.14 7.14 3.02 
t-
value 
-2.5920 -2.9060 -1.7765 
P 
value 
0.0110* 0.0045* 0.0788 
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